Wynn Michelle L, Chang Stella, Peipins Lucy A
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
J Womens Health (Larchmt). 2007 Sep;16(7):971-86. doi: 10.1089/jwh.2006.0300.
The late stage at which ovarian cancer is typically diagnosed and its subsequent high mortality have been attributed to a lack of symptoms in its early stages. This study examined the temporal patterns of prediagnostic ovarian cancer symptoms and conditions among women with and without ovarian cancer.
We identified 920 ovarian cancer cases from 1998-2002 claims and encounters from Thomson Healthcare's Medstat MarketScan Commercial Claims and Encounters and Medicare Supplemental Databases. These were matched with 2760 comparison women based on age, geographic region, Medicare eligibility, and health plan type. The rates of ovarian cancer-related symptoms, conditions, and procedures recorded in the claims data were compared between the two groups using chi-square and Student's t tests.
In the 270 to 31 days prior to the case diagnosis dates, cases had nearly five times more recorded abdominal symptoms (36.2% vs. 7.5%), 3.5 times more recorded female genital symptoms (9.8% vs. 2.7%), and 1.5-2 times more recorded gastrointestinal symptoms (7.7% vs. 3.5%), urethra/urinary tract disorders (12.7% vs. 6.4%), and menopausal disorders (12.4% vs. 7.5%) than the comparison women. However, when the data were examined in 30-day increments for these five diagnosed conditions, the rates for cases and comparison women only started to diverge as the cases' diagnosis drew closer-60-90 days prior.
The presence of ovarian cancer-related symptoms and conditions prior to diagnosis among cases was documented in claims data; however, this increase was most pronounced in the 2-3 months prior to diagnosis. It is likely that physicians will see similar symptoms and conditions for women with and without ovarian cancer during most of the 9 months prior to the cases' diagnosis.
卵巢癌通常在晚期才被诊断出来,其随后的高死亡率被归因于早期缺乏症状。本研究调查了患有和未患有卵巢癌的女性在诊断前卵巢癌症状和疾病的时间模式。
我们从汤姆森医疗保健公司的Medstat市场扫描商业索赔和医保补充数据库中,识别出1998年至2002年期间的920例卵巢癌病例。根据年龄、地理区域、医保资格和健康计划类型,将这些病例与2760名对照女性进行匹配。使用卡方检验和学生t检验比较两组索赔数据中记录的与卵巢癌相关的症状、疾病和治疗程序的发生率。
在病例诊断日期前270至31天,病例记录的腹部症状(36.2%对7.5%)几乎是对照女性的五倍,记录的女性生殖系统症状(9.8%对2.7%)是对照女性的3.5倍,记录的胃肠道症状(7.7%对3.5%)、尿道/泌尿系统疾病(12.7%对6.4%)和更年期疾病(12.4%对7.5%)是对照女性的1.5至2倍。然而,当对这五种已诊断疾病的数据以30天为增量进行检查时,病例组和对照女性的发生率直到病例诊断前60至90天临近时才开始出现差异。
索赔数据记录了病例在诊断前存在与卵巢癌相关的症状和疾病;然而,这种增加在诊断前2至3个月最为明显。在病例诊断前的9个月中的大部分时间里,医生可能会在患有和未患有卵巢癌的女性中看到类似的症状和疾病。